Respiratory Distress Syndrome (RDS) is a respiratory disorder that can affect preterm newborns. It is due to lung immaturity and a deficiency of lung surfactant, a thin lipoprotein layer which allows lung expansion and prevents alveolar collapse during expiration. In these babies, nasal Continuous Positive Airway Pressure (nCPAP) provides non-invasive respiratory support by alveolar recruitment and improves functional residual capacity during spontaneous breathing. In case nCPAP fails, the next step is treatment with exogenous surfactant, which improves gas exchange and survival, reducing the need for mechanical ventilation and then the incidence of chronic lung disease. Although surfactant replacement therapy remains the gold standard for ...
We studied surfactant kinetics on Day 1 of life in 11 preterm infants on mechanical ventilation by i...
Objective: Treatment of preterm infants with respiratory distress syndrome (RDS) with exogenous surf...
The function of pulmonary surfactant of a group of 14 preterm neonates (birth weight 907 +/- 60 g) w...
Respiratory distress syndrome is a common problem in preterm infants and the etiology is multifactor...
Developmental deficiency in pulmonary surfactant leads to respiratory distress syndrome (RDS) in pre...
Objective: Metabolomics is a technique used to non-invasively determine a snapshot of the current me...
Aim: Respiratory distress syndrome (RDS) is a major cause of mortality and morbidity in premature in...
Respiratory distress syndrome (RDS) is a major cause of neonatal mortality and morbidity, especially...
Respiratory distress syndrome (RDS) is a common consequence of pulmonary immaturity in the lungs of ...
Surfactant deficiency and the resultant respiratory distress syndrome (RDS) seen in preterm infants ...
We studied surfactant kinetics on Day 1 of life in 11 preterm infants on mechanical ventilation by i...
Objective: Treatment of preterm infants with respiratory distress syndrome (RDS) with exogenous surf...
The function of pulmonary surfactant of a group of 14 preterm neonates (birth weight 907 +/- 60 g) w...
Respiratory distress syndrome is a common problem in preterm infants and the etiology is multifactor...
Developmental deficiency in pulmonary surfactant leads to respiratory distress syndrome (RDS) in pre...
Objective: Metabolomics is a technique used to non-invasively determine a snapshot of the current me...
Aim: Respiratory distress syndrome (RDS) is a major cause of mortality and morbidity in premature in...
Respiratory distress syndrome (RDS) is a major cause of neonatal mortality and morbidity, especially...
Respiratory distress syndrome (RDS) is a common consequence of pulmonary immaturity in the lungs of ...
Surfactant deficiency and the resultant respiratory distress syndrome (RDS) seen in preterm infants ...
We studied surfactant kinetics on Day 1 of life in 11 preterm infants on mechanical ventilation by i...
Objective: Treatment of preterm infants with respiratory distress syndrome (RDS) with exogenous surf...
The function of pulmonary surfactant of a group of 14 preterm neonates (birth weight 907 +/- 60 g) w...